The estimated Net Worth of Amy S Paul is at least $2.09 Million dollars as of 10 March 2020. Ms. Paul owns over 10,309 units of Wright Medical NV stock worth over $1,795,472 and over the last 9 years she sold WMGI stock worth over $0. In addition, she makes $293,715 as Non-Executive Independent Director at Wright Medical NV.
Amy has made over 3 trades of the Wright Medical NV stock since 2019, according to the Form 4 filled with the SEC. Most recently she exercised 10,309 units of WMGI stock worth $183,706 on 10 March 2020.
The largest trade she's ever made was exercising 10,309 units of Wright Medical NV stock on 10 March 2020 worth over $183,706. On average, Amy trades about 1,819 units every 22 days since 2015. As of 10 March 2020 she still owns at least 59,889 units of Wright Medical NV stock.
You can see the complete history of Ms. Paul stock trades at the bottom of the page.
Amy S. Paul serves as Non-Executive Independent Director of the Company. Ms. Paul was a member of the board of directors of Wright Medical Group, Inc. from 2008 to 2015. Ms. Paul retired in 2008 following a 26-year career with C.R. Bard, Inc., a medical device company, most recently serving as the Group Vice President-International since 2003. She served in various positions at C.R. Bard, Inc. from 1982 to 2003, including President of Bard Access Systems, Inc., President of Bard Endoscopic Technologies, Vice President and Business Manager of Bard Ventures, Vice President of Marketing of Bard Cardiopulmonary Division, Marketing Manager for Davol Inc., and Senior Product Manager for Davol Inc. Ms. Paul previously served on the board of directors of Derma Sciences, Inc., a publicly held company acquired by Integra LifeSciences Holdings Corporation, Viking Systems, Inc., a publicly held company acquired by Conmed Corporation, and was a commissioner of the Northwest Commission on Colleges and Universities from 2010 to 2013. Ms. Paul serves on the President’s Innovation Network at Westminster College. Ms. Paul’s qualifications to serve on our board of directors include her over three decades of experience in the medical device industry, including having served in various executive roles with responsibilities that include international and divisional operations as well as marketing and sales functions, her experience as a director of other public companies in the healthcare industry, and her prior experience as a director of legacy Wright.
As the Non-Executive Independent Director of Wright Medical NV, the total compensation of Amy Paul at Wright Medical NV is $293,715. There are 14 executives at Wright Medical NV getting paid more, with Robert Palmisano having the highest compensation of $7,309,180.
Amy Paul is 68, she's been the Non-Executive Independent Director of Wright Medical NV since 2015. There are 2 older and 21 younger executives at Wright Medical NV. The oldest executive at Wright Medical Group NV is Robert Palmisano, 75, who is the President and Chief Executive Officer, Executive Director.
Amy's mailing address filed with the SEC is 1023 CHERRY ROAD, 1023, MEMPHIS, TN, 38117.
Over the last 9 years, insiders at Wright Medical NV have traded over $526,674,381 worth of Wright Medical NV stock and bought 118,654 units worth $2,654,459 . The most active insiders traders include Sean Carney, Elizabeth H Weatherman, and Holdings Cooperatief U.A.Wa.... On average, Wright Medical NV executives and independent directors trade stock every 9 days with the average trade being worth of $4,402,563. The most recent stock trade was executed by Tim Lanier on 17 August 2020, trading 951 units of WMGI stock currently worth $28,644.
Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.
Wright Medical NV executives and other stock owners filed with the SEC include: